Artemis Therapeutics, Inc. [ATMS]

Source: 

Company Overview

Until January 10, 2019, we were engaged in the development of agents for the prevention and treatment of severe and potentially life-threatening infectious diseases. On January 10, 2019, we received a notice regarding the immediate termination of a certain license agreement, dated May 31, 2016 (the License Agreement), executed by and between the Company, Hadasit Medical Research Services and Development Ltd.